Thyrocare Technologies Limited — Board Meeting, 28-01-2026: Outcome of Board Meeting
28-01-2026 | 04:14 pm
28-01-2026 | 04:14 pm
Thyrocare's board approved Q3 & 9M FY26 consolidated financial results. Q3 revenue hit ₹195.53 Cr (profit ₹29.01 Cr), 9M revenue ₹605.09 Cr (profit ₹115.93 Cr). Results include ₹6.16 Cr in exceptional costs. The board also amended its insider trading code.
No comments yet. Be the first to comment!
